Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | SVP, CFO | March 01, 2023 | March 10, 2023 |
| Veralto CorpVLTO · Entity 3203 | SVP, Chief Financial Officer | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date March 01, 2023 · Filed March 10, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.32 · Expires 2023-03-01 | Direct | 28,807 |
Reported balance
After 2023-03-01 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-03-01 · Grant · Acquired 28,807 · Balance 28,807 F1: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F2: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person. F3: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
F2: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.
F3: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.
Veralto Corp
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,694 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Tax withholding · Disposed 3,305 · Balance 53,694 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 17, 2026 21:11 UTC | Veralto Corp VLTO · Entity 3203 | Tax withholdingCommon Stock | 3,305 | $91.00 | $300,755.00 |
DisclosureSEC source: 0001778813-26-000005 · wk-form4_1784322667.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,694 Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:12 UTC | Veralto Corp VLTO · Entity 3203 | GrantEmployee Stock Option (Right to Buy) · Derivative | 24,774 | $0.00 Strike: $97.43 | $0.00 |
DisclosureSEC source: 0001778813-26-000003 · wk-form4_1772575917.xml · derivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,774 Underlying: Common Stock · 24,774 shares Expires 2036-03-01 F2 · derivative.exercise_date: One half of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:12 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 7,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001778813-26-000003 · wk-form4_1772575917.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,999 F1 · shares: On the date indicated, Veralto Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One half of the RSUs vest on each of the third and fourth anniversaries of the grant date, which is March 1, 2026. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 22:01 UTC | Veralto Corp VLTO · Entity 3203 | GrantVeralto Excess Contribution Program - Veralto Stock Fund · Derivative | 969 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-26-000005 · wk-form4_1770415302.xml · derivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 969 shares Expires not disclosed F1 · security: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto") to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on February 5, 2026 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 2, 2026. F2 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F3 · shares: The acquired shares account for ECP Match Contribution and ECP Nonelective Contribution. F4 · derivative.exercise_date: The vesting terms and manner and form of the distribution of amounts contributed or deferred under the program are based upon provisions of the Company's deferred compensation program, which provisions are summarized in the Company's annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. F4 · derivative.expiration_date: The vesting terms and manner and form of the distribution of amounts contributed or deferred under the program are based upon provisions of the Company's deferred compensation program, which provisions are summarized in the Company's annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. F1 · derivative.underlying_shares: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto") to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on February 5, 2026 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 2, 2026. F1 · balance_after: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto") to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on February 5, 2026 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 2, 2026. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 22:52 UTC | Veralto Corp VLTO · Entity 3203 | Tax withholdingCommon Stock | 3,361 | $98.78 | $331,999.58 |
DisclosureSEC source: 0001778813-25-000005 · wk-form4_1763419969.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,686 Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:59 UTC | Veralto Corp VLTO · Entity 3203 | GrantEmployee Stock Option (Right to Buy) · Derivative | 18,704 | $0.00 Strike: $99.76 | $0.00 |
DisclosureSEC source: 0001967680-25-000041 · wk-form4_1741129138.xml · derivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,704 Underlying: Common Stock · 18,704 shares Expires 2035-03-01 F2 · derivative.exercise_date: One half of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is March 1, 2025. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:59 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 6,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-25-000041 · wk-form4_1741129138.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,047 F1 · shares: On the date indicated, Veralto Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One half of the RSUs vest on each of the third and fourth anniversaries of the grant date, which is March 1, 2025. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 22:20 UTC | Veralto Corp VLTO · Entity 3203 | GrantVeralto Excess Contribution Program - Veralto Stock Fund · Derivative | 703 | $103.39 | $72,683.17 |
DisclosureSEC source: 0001967680-25-000024 · wk-form4_1740781207.xml · derivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 906 Underlying: Common Stock · 703 shares Expires not disclosed F1 · security: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto) to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on February 26, 2025 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 3, 2025. F2 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F3 · derivative.exercise_date: The vesting terms and manner and form of the distribution of amounts contributed or deferred under the program are based upon provisions of the Company's deferred compensation program, which provisions are summarized in the Company's annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. F3 · derivative.expiration_date: The vesting terms and manner and form of the distribution of amounts contributed or deferred under the program are based upon provisions of the Company's deferred compensation program, which provisions are summarized in the Company's annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. F1 · derivative.underlying_shares: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto) to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on February 26, 2025 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 3, 2025. F1 · balance_after: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto) to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on February 26, 2025 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 3, 2025. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 22:05 UTC | Veralto Corp VLTO · Entity 3203 | Tax withholdingCommon Stock | 3,833 | $102.68 | $393,572.44 |
DisclosureSEC source: 0001967680-24-000145 · wk-form4_1732140295.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,280 Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:09 UTC | Veralto Corp VLTO · Entity 3203 | GrantExecutive Deferred Incentive Program (Veralto Stock Fund) · Derivative | 203 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-24-000037 · wk-form4_1710277770.xml · derivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203 Underlying: Common Stock · 203 shares Expires not disclosed F1 · security: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto") to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on March 11, 2024 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 1, 2024. F2 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F3 · derivative.exercise_date: The vesting terms and manner and form of the distribution of amounts contributed or deferred under the program are based upon provisions of the Company's registration statement on Form 10, which provisions will be summarized in the Veralto Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. F3 · derivative.expiration_date: The vesting terms and manner and form of the distribution of amounts contributed or deferred under the program are based upon provisions of the Company's registration statement on Form 10, which provisions will be summarized in the Veralto Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. F1 · derivative.underlying_shares: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto") to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on March 11, 2024 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 1, 2024. F1 · balance_after: Represents the annual contribution by Veralto Corporation (the "Company" or "Veralto") to the Veralto stock fund in the reporting person's account under one or more of the plans that form part of Veralto's deferred compensation program and effectuated on March 11, 2024 by the plan administrator. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Veralto common stock as of February 1, 2024. Read SEC document |
| February 24, 2024 Filed Feb 28, 2024 01:12 UTC | Veralto Corp VLTO · Entity 3203 | GrantEmployee Stock Option (Right to Buy) · Derivative | 17,976 | $0.00 Strike: $86.71 | $0.00 |
DisclosureSEC source: 0001967680-24-000025 · wk-form4_1709082719.xml · derivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,976 Underlying: Common Stock · 17,976 shares Expires 2034-02-24 F2 · derivative.exercise_date: One half of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is February 24, 2024. Read SEC document |
| February 24, 2024 Filed Feb 28, 2024 01:12 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 7,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-24-000025 · wk-form4_1709082719.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,113 F1 · shares: On the date indicated, Veralto Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One half of the RSUs vest on each of the third and fourth anniversaries of the grant date, which is February 24, 2024. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:28 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 27,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-23-000034 · wk-form4_1700260128.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,616 F1 · shares: Reflects a grant of restricted stock units, of which one-third vests on each of the first three anniversaries of the grant date, which is November 15, 2023. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 22:57 UTC | Veralto Corp VLTO · Entity 3203 | GrantEmployee stock option (right to buy) · Derivative | 44,446 | Not disclosed Strike: $80.36 | Not disclosed |
DisclosureSEC source: 0001209191-23-051702 · doc4.xml · derivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,446 Underlying: Common stock · 44,446 shares Expires 2033-07-15 F1 · kind: Represents equity awards originally granted by Danaher Corporation ("Danaher") that have been converted into equity awards of Veralto Corporation ("Veralto") in connection with the spin-off of Veralto from Danaher (the "Spin-off"). F1 · price: Represents equity awards originally granted by Danaher Corporation ("Danaher") that have been converted into equity awards of Veralto Corporation ("Veralto") in connection with the spin-off of Veralto from Danaher (the "Spin-off"). F3 · derivative.exercise_date: Represents stock options that vest in two equal annual installments beginning on July 15, 2026, subject to continued employment. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 22:57 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 15,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-051702 · doc4.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,556 F1 · kind: Represents equity awards originally granted by Danaher Corporation ("Danaher") that have been converted into equity awards of Veralto Corporation ("Veralto") in connection with the spin-off of Veralto from Danaher (the "Spin-off"). F2 · shares: Represents restricted stock units ("RSUs") issued by Danaher and converted into RSUs of Veralto which remain unvested as of the Spin-off, vesting in two equal annual installments beginning on July 15, 2026. F1 · price: Represents equity awards originally granted by Danaher Corporation ("Danaher") that have been converted into equity awards of Veralto Corporation ("Veralto") in connection with the spin-off of Veralto from Danaher (the "Spin-off"). Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC | Chemours Co CC · Entity 4420 | GrantPerformance Stock Options (Right to Buy) · Derivative | 27,679 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · derivative · entry 4 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,679 Underlying: Common Stock · 27,679 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 28,076 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · derivative · entry 3 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,076 Underlying: Common Stock · 28,076 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 12,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,345.8611 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 1,842 | $34.84 | $64,175.28 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,967.8611 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 10, 2023 18:50 UTC Amendment | Chemours Co CC · Entity 4420 | GrantPerformance Stock Option (Right to Buy) · Derivative | 28,807 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-017759 · doc4a.xml · derivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,807 Underlying: Common Stock · 28,807 shares Expires 2023-03-01 F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person. F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 19:22 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 42,218 | $34.35 | $1,450,188.30 |
DisclosureSEC source: 0001209191-23-009053 · doc4.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,710.0122 F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 19:22 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 98,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009053 · doc4.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,928.0122 F1 · shares: Vesting of performance share units (PSUs) F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| May 09, 2022 Filed May 9, 2022 22:21 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,175 | $0.00 Strike: $5.40 | $0.00 |
DisclosureSEC source: 0001627223-22-000040 · primary_doc.xml · derivative · entry 6 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,175 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017. Read SEC document |
| May 09, 2022 Filed May 9, 2022 22:21 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 20,175 | $40.01 | $807,201.75 |
DisclosureSEC source: 0001627223-22-000040 · primary_doc.xml · nonDerivative · entry 4 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,506.2256 F3 · price: Shares were sold in multiple transactions at prices ranging from $40.00 to $40.06. F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| May 09, 2022 Filed May 9, 2022 22:21 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 20,175 | $5.40 | $108,945.00 |
DisclosureSEC source: 0001627223-22-000040 · primary_doc.xml · nonDerivative · entry 3 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,681.2256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| May 06, 2022 Filed May 9, 2022 22:21 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 35,188 | $0.00 Strike: $5.40 | $0.00 |
DisclosureSEC source: 0001627223-22-000040 · primary_doc.xml · derivative · entry 5 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,175 Underlying: Common Stock · 35,188 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017. Read SEC document |
| May 06, 2022 Filed May 9, 2022 22:21 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 35,188 | $40.14 | $1,412,446.32 |
DisclosureSEC source: 0001627223-22-000040 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,506.2256 F2 · price: Shares were sold in multiple transactions at prices ranging from $40.00 to $40.32. F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| May 06, 2022 Filed May 9, 2022 22:21 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 35,188 | $5.40 | $190,015.20 |
DisclosureSEC source: 0001627223-22-000040 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,694.2256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 13:53 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 65,722 | $0.00 Strike: $25.98 | $0.00 |
DisclosureSEC source: 0001627223-22-000016 · primary_doc.xml · derivative · entry 3 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,722 Underlying: Common Stock · 65,722 shares Expires 2032-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2023. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 13:53 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 6,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-22-000016 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,091.4634 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2023. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 13:53 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 550 | $25.98 | $14,289.00 |
DisclosureSEC source: 0001627223-22-000016 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,837.4634 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 23:52 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 3,975 | $30.00 | $119,250.00 |
DisclosureSEC source: 0001627223-22-000009 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,388.1398 F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 23:52 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 11,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-22-000009 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,363.1398 F1 · shares: Vesting of performance share units (PSUs) F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:28 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,482 | $0.00 Strike: $18.45 | $0.00 |
DisclosureSEC source: 0001627223-21-000052 · primary_doc.xml · derivative · entry 3 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,482 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F4 · derivative.exercise_date: Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:28 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 17,482 | $29.85 | $521,837.70 |
DisclosureSEC source: 0001627223-21-000052 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,149.9063 F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F3 · price: Shares were sold in multiple transactions at prices ranging from $29.55 to $30.08. F2 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:28 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 17,482 | $18.45 | $322,542.90 |
DisclosureSEC source: 0001627223-21-000052 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,631.9063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F2 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| August 30, 2021 Filed Aug 30, 2021 23:56 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,890 | $0.00 Strike: $18.45 | $0.00 |
DisclosureSEC source: 0001627223-21-000045 · primary_doc.xml · derivative · entry 3 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,482 Underlying: Common Stock · 1,890 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F3 · derivative.exercise_date: Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016. Read SEC document |
| August 30, 2021 Filed Aug 30, 2021 23:56 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 1,890 | $35.00 | $66,150.00 |
DisclosureSEC source: 0001627223-21-000045 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,792 F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F2 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| August 30, 2021 Filed Aug 30, 2021 23:56 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 1,890 | $18.45 | $34,870.50 |
DisclosureSEC source: 0001627223-21-000045 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F2 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:09 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,085 | $0.00 Strike: $18.45 | $0.00 |
DisclosureSEC source: 0001627223-21-000040 · primary_doc.xml · derivative · entry 3 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,372 Underlying: Common Stock · 15,085 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F4 · derivative.exercise_date: Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:09 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 15,085 | $35.00 | $527,975.00 |
DisclosureSEC source: 0001627223-21-000040 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,792 F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F3 · price: Shares were sold in multiple transactions at prices ranging from $35.00 to $35.01. F2 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:09 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 15,085 | $18.45 | $278,318.25 |
DisclosureSEC source: 0001627223-21-000040 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. F2 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 18:16 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 49,079 | $0.00 Strike: $24.01 | $0.00 |
DisclosureSEC source: 0001627223-21-000016 · primary_doc.xml · derivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,079 Underlying: Common Stock · 49,079 shares Expires 2031-03-01 F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 18:16 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 4,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000016 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,116.8489 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:13 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 224 | $26.14 | $5,855.36 |
DisclosureSEC source: 0001627223-21-000005 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,119.8489 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F3 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:13 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 597 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000005 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,343.8489 F1 · shares: Vesting of performance share units (PSUs) F3 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 17:46 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 39,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000045 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,647 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on December 1, 2023. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:51 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 106,951 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000018 · primary_doc.xml · derivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,951 Underlying: Common Stock · 106,951 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:53 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 2,002 | $19.37 | $38,778.74 |
DisclosureSEC source: 0001627223-20-000011 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,137 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:53 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 5,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000011 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,139 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.